Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit-Reference-Cited by-同舟云学术

Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit

Published:1986-01 Issue:1 Volume:41 Page:33-41
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Matsuo T.,Nakao K.,Yamada T.,Matsuo O.

Publisher

Elsevier BV

Subject

Hematology

Reference16 articles.

1. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers;Gunnarsson;Clinical Nephrology,1981

2. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation;Bertelé;Thrombos.Haemostas.,1983

3. Anticoagulant therapy;Deykin,1982

4. Comparative study on heparin and a synthetic thrombin inhibitor No. 805 (MD-805) in experimental antithrombin III-deficient animals;Kumada;Thromb. Res.,1981

5. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805;Okamoto,1981

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Index Digit Necrosis as a Complication of Radial Artery Cannulation;Cureus;2022-08-27

2. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients;Thrombosis Research;2012-04

3. Simultaneous Use of Argatroban and Heparin during Cardiopulmonary Bypass;Asian Cardiovascular and Thoracic Annals;2010-02

4. Argatroban Anticoagulation in Renal Dysfunction: A Literature Analysis;Nephron Clinical Practice;2008

5. Current Use of Anticoagulation in Hemodialysis;Seminars in Dialysis;2007-10-01